Celldex Therapeutics, Inc. Gains 25.49%
Mon, Jul 12, 2021 at 05:33 PM
Celldex Therapeutics, Inc. (CLDX:NASDAQ) shot up at $40.67, a gain of 25.5%. The stock appeared on our News Catalysts scanner on Mon, Jul 12, 2021 at 12:35 PM in the 'MISCELLANEOUS' category. From Fri, Jun 25, 2021, the stock recorded 55.56% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Celldex Therapeutics, Inc. (CLDX:NASDAQ)
Celldex Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.
Top 10 Gainers:
- Mediaco Holding Inc. (MDIA:NASDAQ), 311.62%
- State Auto Financial Corporation (STFC:NASDAQ), 190.96%
- SGOCO Group, Ltd. (SGOC:NASDAQ), 104.29%
- SCWorx Corp. (WORX:NASDAQ), 59.28%
- TPST (TPST:NASDAQ), 54.37%
- Origin Agritech Limited (SEED:NASDAQ), 40.89%
- CRTD (CRTD:NASDAQ), 33.17%
- Cemtrex, Inc. (CETX:NASDAQ), 31.54%
- Ayala Pharmaceuticals, Inc. (AYLA:NASDAQ), 28.8%
- Celldex Therapeutics, Inc. (CLDX:NASDAQ), 25.49%